OpenLB
Open Library of Bioscience
Advanced Search
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
2018 Sep-Oct;44 (5): 405-423.

2018 recommendations for the management of community acquired pneumonia.

Ricardo de Amorim Corr��a, Andre Nathan Costa, Fernando Lundgren, Lessandra Michelin, Mara R��bia Figueiredo, Marcelo Holanda, Mauro Gomes, Paulo Jos�� Zimermann Teixeira, Ricardo Martins, Rodney Silva, Rodrigo Abensur Athanazio, Rosemeri Maurici da Silva, M��nica Corso Pereira
Author Information
  1. Ricardo de Amorim Corr��a: . Faculdade de Medicina, Universidade Federal de Minas Gerais - UFMG - Belo Horizonte (MG) Brasil. ORCID
  2. Andre Nathan Costa: . Faculdade de Medicina, Universidade de S��o Paulo - USP - S��o Paulo (SP) Brasil. ORCID
  3. Fernando Lundgren: . Hospital Ot��vio de Freitas, Recife (PE) Brasil. ORCID
  4. Lessandra Michelin: . Faculdade de Medicina, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil. ORCID
  5. Mara R��bia Figueiredo: . Hospital de Messejana Dr Carlos Alberto Studart Gomes, Fortaleza (CE) Brasil. ORCID
  6. Marcelo Holanda: . Faculdade de Medicina, Universidade Federal do Cear�� - UFC - Fortaleza (CE) Brasil. ORCID
  7. Mauro Gomes: . Faculdade de Ci��ncias M��dicas, Santa Casa de S��o Paulo, S��o Paulo (SP) Brasil. ORCID
  8. Paulo Jos�� Zimermann Teixeira: . Universidade Federal de Ci��ncias da Sa��de de Porto Alegre, Porto Alegre (RJ) Brasil. ORCID
  9. Ricardo Martins: . Faculdade de Medicina, Universidade de Bras��lia - UnB - Bras��lia (DF) Brasil. ORCID
  10. Rodney Silva: . Faculdade de Medicina, Universidade Federal do Paran�� - UFPR - Curitiba (PR) Brasil. ORCID
  11. Rodrigo Abensur Athanazio: . Faculdade de Medicina, Universidade de S��o Paulo - USP - S��o Paulo (SP) Brasil. ORCID
  12. Rosemeri Maurici da Silva: . Faculdade de Medicina, Universidade Federal de Santa Catarina - UFSC - Florian��polis (SC) Brasil. ORCID
  13. M��nica Corso Pereira: . Faculdade de Medicina, Universidade Estadual de Campinas - Unicamp - Campinas (SP) Brasil. ORCID
PMID: 30517341 DOI: 10.1590/S1806-37562018000000130

Abstract

Community-acquired pneumonia (CAP) is the leading cause of death worldwide. Despite the vast diversity of respiratory microbiota, Streptococcus pneumoniae remains the most prevalent pathogen among etiologic agents. Despite the significant decrease in the mortality rates for lower respiratory tract infections in recent decades, CAP ranks third as a cause of death in Brazil. Since the latest Guidelines on CAP from the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association) were published (2009), there have been major advances in the application of imaging tests, in etiologic investigation, in risk stratification at admission and prognostic score stratification, in the use of biomarkers, and in the recommendations for antibiotic therapy (and its duration) and prevention through vaccination. To review these topics, the SBPT Committee on Respiratory Infections summoned 13 members with recognized experience in CAP in Brazil who identified issues relevant to clinical practice that require updates given the publication of new epidemiological and scientific evidence. Twelve topics concerning diagnostic, prognostic, therapeutic, and preventive issues were developed. The topics were divided among the authors, who conducted a nonsystematic review of the literature, but giving priority to major publications in the specific areas, including original articles, review articles, and systematic reviews. All authors had the opportunity to review and comment on all questions, producing a single final document that was approved by consensus.

References

  1. BMJ. 2014 Dec 03;349:g6722 [PMID: 25471702]
  2. Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59 [PMID: 21951385]
  3. Lancet. 2015 Sep 12;386(9998):1097-108 [PMID: 26277247]
  4. Clin Respir J. 2018 Apr;12(4):1320-1360 [PMID: 28756639]
  5. PLoS One. 2015 Jun 26;10(6):e0130217 [PMID: 26114297]
  6. Lancet. 2015 Apr 18;385(9977):1511-8 [PMID: 25608756]
  7. Clin Infect Dis. 2016 Aug 1;63(3):300-9 [PMID: 27161775]
  8. Scand J Infect Dis. 2011 Aug;43(8):609-15 [PMID: 21466255]
  9. Semin Respir Crit Care Med. 2016 Dec;37(6):819-828 [PMID: 27960206]
  10. JAMA. 2015 Feb 17;313(7):677-86 [PMID: 25688779]
  11. Hum Vaccin Immunother. 2016 Dec;12(12):3056-3064 [PMID: 27629584]
  12. Crit Care. 2011 Mar 15;15(2):R96 [PMID: 21406101]
  13. Lancet Infect Dis. 2015 May;15(5):535-43 [PMID: 25801458]
  14. Crit Care Med. 2014 Feb;42(2):420-32 [PMID: 24158175]
  15. N Engl J Med. 1997 Jan 23;336(4):243-50 [PMID: 8995086]
  16. Crit Care. 2012 Dec 12;16(2):R53 [PMID: 22449513]
  17. J Bras Pneumol. 2009 Jun;35(6):574-601 [PMID: 19618038]
  18. Scand J Prim Health Care. 2016;34(1):21-7 [PMID: 26849394]
  19. BMC Infect Dis. 2014 Oct 18;14:534 [PMID: 25326650]
  20. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 [PMID: 17278083]
  21. Chest. 2017 Feb;151(2):374-382 [PMID: 27818332]
  22. PLoS One. 2017 May 23;12(5):e0177985 [PMID: 28542347]
  23. Crit Care. 2012 Nov 18;16(6):R223 [PMID: 23158399]
  24. JAMA. 2016 Feb 9;315(6):593-602 [PMID: 26864413]
  25. Am J Emerg Med. 2014 Feb;32(2):115-8 [PMID: 24184011]
  26. Arch Bronconeumol. 2004 Aug;40(8):364-74 [PMID: 15274866]
  27. Thorax. 2015 Jul;70(7):698-700 [PMID: 25977290]
  28. MMWR Morb Mortal Wkly Rep. 2016 Sep 30;65(38):1026-31 [PMID: 27684642]
  29. Thorax. 2013 Nov;68(11):1057-65 [PMID: 24130229]
  30. Thorax. 2001 Mar;56 Suppl 1:i1-21 [PMID: 11158709]
  31. Thorax. 2012 Jan;67(1):71-9 [PMID: 20729232]
  32. Front Microbiol. 2015 Aug 05;6:791 [PMID: 26300860]
  33. BMC Infect Dis. 2007 Mar 02;7:10 [PMID: 17335562]
  34. Open Forum Infect Dis. 2017 Jun 20;4(2):ofx088 [PMID: 28730159]
  35. Thorax. 2010 Oct;65(10):884-90 [PMID: 20729235]
  36. Am J Med. 2007 Sep;120(9):783-90 [PMID: 17765048]
  37. Lancet Respir Med. 2014 Mar;2(3):238-46 [PMID: 24621685]
  38. Cochrane Database Syst Rev. 2014 Mar 13;(3):CD001269 [PMID: 24623315]
  39. Eur Respir J. 2007 Sep;30(3):556-73 [PMID: 17766633]
  40. Thorax. 2000 Mar;55(3):219-23 [PMID: 10679541]
  41. J Antimicrob Chemother. 2016 Apr;71(4):862-70 [PMID: 26702925]
  42. Jpn J Radiol. 2015 Jun;33(6):317-28 [PMID: 25895159]
  43. N Engl J Med. 2005 Oct 20;353(16):1711-23 [PMID: 16236742]
  44. Drugs. 2008;68(13):1841-54 [PMID: 18729535]
  45. Medicine (Baltimore). 2016 Jul;95(27):e4153 [PMID: 27399134]
  46. Med Clin (Barc). 2017 Jun 7;148(11):501-510 [PMID: 28391994]
  47. Rev Chilena Infectol. 2014 Oct;31(5):607-9 [PMID: 25491461]
  48. Recent Pat Inflamm Allergy Drug Discov. 2015;9(1):23-30 [PMID: 25706527]
  49. Thorax. 2009 Oct;64 Suppl 3:iii1-55 [PMID: 19783532]
  50. Scand J Clin Lab Invest. 2017 Nov;77(7):486-492 [PMID: 28678546]
  51. JAMA. 2014 Jun 4;311(21):2199-208 [PMID: 24893087]
  52. J Infect. 2013 Jul;67(1):11-8 [PMID: 23523447]
  53. Medicine (Baltimore). 2017 Jan;96(3):e5713 [PMID: 28099332]
  54. Crit Care. 2013 Nov 07;17(6):R265 [PMID: 24200097]
  55. Crit Care. 2012 Jul 27;16(4):R141 [PMID: 22839689]
  56. Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95 [PMID: 23855620]
  57. PLoS One. 2016 Nov 15;11(11):e0165942 [PMID: 27846240]
  58. N Engl J Med. 2013 Jul 11;369(2):155-63 [PMID: 23841730]
  59. Infect Dis Clin North Am. 2013 Mar;27(1):19-31 [PMID: 23398863]
  60. Expert Opin Pharmacother. 2018 Apr;19(5):457-470 [PMID: 29480032]
  61. Chest. 2018 Mar;153(3):583-585 [PMID: 29519296]
  62. Expert Opin Pharmacother. 2005 Oct;6(13):2335-51 [PMID: 16218893]
  63. Am J Emerg Med. 2018 Feb;36(2):179-184 [PMID: 28756034]
  64. J Korean Med Sci. 2017 Jan;32(1):77-84 [PMID: 27914135]
  65. N Engl J Med. 2014 Oct 23;371(17):1619-28 [PMID: 25337751]
  66. Chest. 2018 Mar;153(3):601-610 [PMID: 28802696]
  67. Expert Rev Anti Infect Ther. 2015;13(9):1109-21 [PMID: 26091895]
  68. Lancet. 2008 Aug 2;372(9636):398-405 [PMID: 18675690]
  69. JAMA Intern Med. 2014 Dec;174(12):1894-901 [PMID: 25286173]
  70. Eur J Radiol. 2008 Mar;65(3):333-9 [PMID: 17954020]
  71. Thorax. 2015 Oct;70(10):984-9 [PMID: 26219979]
  72. Clin Infect Dis. 2008 Aug 1;47(3):375-84 [PMID: 18558884]
  73. Curr Opin Pulm Med. 2017 May;23(3):204-210 [PMID: 28198726]
  74. Intensive Care Med. 2010 Apr;36(4):612-20 [PMID: 19953222]
  75. J Infect. 2010 Feb;60(2):106-13 [PMID: 19961875]
  76. Clin Infect Dis. 2003 Nov 1;37(9):1257-60 [PMID: 14557972]
  77. Age Ageing. 1972 Nov;1(4):233-8 [PMID: 4669880]
  78. Intensive Care Med. 2009 Jan;35(1):9-29 [PMID: 18989656]
  79. Crit Care. 2015 Sep 10;19:335 [PMID: 26369551]
  80. J Antimicrob Chemother. 2014 Feb;69(2):515-8 [PMID: 24022067]
  81. Clin Microbiol Infect. 2014 May;20 Suppl 5:52-8 [PMID: 24410778]
  82. BMJ. 2017 Jul 10;358:j2471 [PMID: 28694251]
  83. Infect Drug Resist. 2009;2:27-40 [PMID: 21694885]
  84. Am J Respir Crit Care Med. 2015 Oct 15;192(8):974-82 [PMID: 26168322]
  85. J R Soc Interface. 2013 Jul 03;10(86):20130233 [PMID: 23825111]
  86. Infect Dis Clin North Am. 2013 Mar;27(1):49-69 [PMID: 23398865]
  87. Eur Respir J. 2006 Jan;27(1):151-7 [PMID: 16387948]
  88. Emerg Med J. 2015 Jun;32(6):433-8 [PMID: 25142033]
  89. Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):305-16 [PMID: 23242464]
  90. Antimicrob Agents Chemother. 2014 Sep;58(9):5262-8 [PMID: 24957843]
  91. Respir Med. 2015 Jan;109(1):1-10 [PMID: 25468412]
  92. Chest. 2014 Jul;146(1):22-31 [PMID: 24371840]
  93. Lancet. 2011 Apr 9;377(9773):1264-75 [PMID: 21435708]
  94. Am J Respir Crit Care Med. 2005 Feb 1;171(3):242-8 [PMID: 15557131]
  95. Rev Assoc Med Bras (1992). 2014 Jan-Feb;60(1):4-15 [PMID: 24918845]
  96. Eur Respir J. 2014 Mar;43(3):842-51 [PMID: 24114960]
  97. Am J Emerg Med. 2015 May;33(5):620-5 [PMID: 25758182]
  98. Infect Dis (Lond). 2017 Apr;49(4):251-260 [PMID: 27887037]
  99. Emerg Radiol. 2007 Nov;14(6):383-8 [PMID: 17701235]
  100. Ann Intern Med. 2015 Oct 6;163(7):519-28 [PMID: 26258555]
  101. Clin Infect Dis. 2003 Sep 15;37(6):752-60 [PMID: 12955634]
  102. Arch Intern Med. 2012 Jun 25;172(12):922-8 [PMID: 22732747]
  103. Am J Respir Crit Care Med. 2010 May 1;181(9):975-82 [PMID: 20133929]
  104. Crit Ultrasound J. 2017 Dec;9(1):6 [PMID: 28244009]
  105. Curr Opin Crit Care. 2017 Oct;23(5):385-390 [PMID: 28777158]
  106. Am J Infect Control. 2014 May;42(5):539-41 [PMID: 24773792]
  107. Chest. 2010 Mar;137(3):552-7 [PMID: 19880910]
  108. Cochrane Database Syst Rev. 2017 Oct 12;10:CD007498 [PMID: 29025194]
  109. Clin Microbiol Infect. 2016 Jun;22(6):567.e1-7 [PMID: 27021421]
  110. Chest. 2016 Jan;149(1):209-19 [PMID: 26501852]
  111. Clin Infect Dis. 2011 Feb 1;52(3):325-31 [PMID: 21217179]
  112. N Engl J Med. 2015 Apr 2;372(14):1312-23 [PMID: 25830421]
  113. Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):171-181 [PMID: 28658381]
  114. Pediatr Infect Dis J. 2008 Dec;27(12):1103-7 [PMID: 18978518]

MeSH Term

Anti-Bacterial Agents
Brazil
Community-Acquired Infections
Consensus Development Conferences as Topic
Evidence-Based Medicine
Humans
Pneumonia, Bacterial
Pneumonia, Viral
Societies, Medical

Chemicals

Anti-Bacterial Agents
Journal Article
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0CAPreviewtopicspneumoniacausedeathDespiterespiratoryamongetiologicBrazilSBPTmajorstratificationprognosticrecommendationsissuesauthorsarticlesCommunity-acquiredleadingworldwidevastdiversitymicrobiotaStreptococcuspneumoniaeremainsprevalentpathogenagentssignificantdecreasemortalityrateslowertractinfectionsrecentdecadesranksthirdSincelatestGuidelinesSociedadeBrasileiradePneumologiaeTisiologiaBrazilianThoracicAssociationpublished2009advancesapplicationimagingtestsinvestigationriskadmissionscoreusebiomarkersantibiotictherapydurationpreventionvaccinationCommitteeRespiratoryInfectionssummoned13membersrecognizedexperienceidentifiedrelevantclinicalpracticerequireupdatesgivenpublicationnewepidemiologicalscientificevidenceTwelveconcerningdiagnostictherapeuticpreventivedevelopeddividedconductednonsystematicliteraturegivingprioritypublicationsspecificareasincludingoriginalsystematicreviewsopportunitycommentquestionsproducingsinglefinaldocumentapprovedconsensus2018managementcommunityacquired

Similar Articles

Cited By (16)